Did you know?

A high-level overview of Soleno Therapeutics, Inc. (SLNO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Track Allarity Therapeutics Inc (ALLR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Array Technologies Inc (ARRY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack reAlpha Tech Corp. (AIRE) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Intel Corp (INTC) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsARQT : 7.84 (-2.24%) Arcutis Biotherapeutics, Inc. (ARQT) Reports Q1 Loss, Lags Revenue Estimates Zacks - Tue May 9, 2023. Arcutis Biotherapeutics, Inc. (ARQT) delivered earnings and revenue surprises of -0.77% and 20.54%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...Track Coherus Biosciences Inc (CHRS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsARQT has a market cap of $180mn and a cash balance of $228mn. For the third quarter, they reported net product revenue of $8.1 million and total revenue of $38mn. R&D expenses were $26.2 million ...Price vs Fair Value. View History. ARQQ is trading at a 614% premium. Price. $0.40. May 10, 2024. Fair Value. $5.99.ARQT rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results. Arcutis Biotherapeutics reported …Track Arcturus Therapeutics Holdings Inc (ARCT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsArcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Just Reported, And Analysts Assigned A US$41.57 Price Target. (Simply Wall St.) Aug-10-23 08:16AM. Arcutis and Huadong Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Greater China and Southeast Asia. (GlobeNewswire) Aug-09-23 09:23AM.SONY, PBR, HD and 123 more stocks reporting earnings Tuesday. 126 reporting. Wednesday. 15. CSCO, ZTO, GRAB and 99 more stocks reporting earnings Wednesday. 102 reporting. Thursday. 16. WMT, UAA, DE and 28 …All of us want to be seen, heard and understood. We especially want this from our partners. We want our partne All of us want to be seen, heard and understood. We especially want t...Learn more. Track C3.ai Inc (AI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.Find the latest Arcturus Therapeutics Holdings Inc. (ARCT) stock quote, history, news and other vital information to help you with your stock trading and investing.Track CRISPR Therapeutics AG (CRSP) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsWe would like to show you a description here but the site won’t allow us.The airline is donating hundreds of flights to send immigrant children back to their parents. United Airlines is again stepping into the immigration controversy unfolding in the US...Track Antero Resources Corp (AR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsZORYVE is for topical use only and not for ophthalmic, oral, or intervaginal use. About Arcutis. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is an early commercial-stage medical dermatology company that champions meaningful innovation to address the urgent needs of individuals living with immune-mediated dermatological diseases and conditions.Get all financial information for Arcutis Biotherapeutics Inc (ARQT) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, 52 week high & 52 week low, Beta and much moreFree ARQT Stock Alerts. $8.13. +0.14 (+1.75%) (As of 04:00 PM ET) Compare. Share. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media. WallStreetBets Posts Over Time. 0.ARQT has a market cap of $180mn and a cash balance of $228mn. For the third quarter, they reported net product revenue of $8.1 million and total revenue of $38mn. R&D expenses were $26.2 million ...The rhythm and pronunciation of English is difeTrack Arcturus Therapeutics Holdings Inc (ARCT) Stock Price, All of us want to be seen, heard and understood. We especially want this from our partners. We want our partne All of us want to be seen, heard and understood. We especially want t...Great discussions are par for the course here on Lifehacker. Each day, we highlight a discussion that is particularly helpful or insightful, along with other great discussions and ... Get the latest Arqit Quantum Inc (ARQQ) real-time quote, historical Stock analysis for Arcutis Biotherapeutics Inc (ARQT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.In this edition of Week in Review, we recap Google's Magic Eraser coming to more devices, Spotify gaining an AI DJ, and Netflix decreasing prices. It’s Friday (or should I say, Fri... ARQT Arcutis Biotherapeutics Inc. 1,823. $8.09. $0.07. (0.87%) Tod

Arcutis Biotherapeutics Stock Performance. Shares of ARQT opened at $7.84 on Monday. The company has a current ratio of 7.08, a quick ratio of 6.80 and a debt-to-equity ratio of 2.28.Westlake Village, CA, February 27, 2024 – Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported financial results for the quarter and year ended December 31, 2023, and provided a business update. “2023 was … According to the issued ratings of 8 analysts in the last year, the consensus rating for Arcutis Biotherapeutics stock is Moderate Buy based on the current 2 hold ratings and 6 buy ratings for ARQT. The average twelve-month price prediction for Arcutis Biotherapeutics is $26.56 with a high price target of $50.00 and a low price target of $8.00. Open 7.92. Bid 7.96 x 200. Ask 8.01 x 1000. Day's Range 7.70 - 8.14. 52 Week Range 1.76 - 13.17. Volume 2,338,550. Avg. Volume 3,788,604. Market Cap (intraday) 923.045M. Beta (5Y Monthly) 1.18. PE...

Track Adaptive Biotechnologies Corp (ADPT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Discover real-time Arcutis Biotherapeutics, Inc. Common Stock (ARQT) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq. Track Rackspace Hosting, Inc (RXT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Arcutis Biotherapeutics (NASDAQ:ARQT) is scheduled to announce Q1 earn. Possible cause: ARQT's short-term technical score of 27 indicates that the stock has traded less bu.